Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-02-08 @ 2:13 AM
Study NCT ID:
NCT07214766
Status:
RECRUITING
Last Update Posted:
2025-12-04
First Post:
2025-10-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
Sponsor:
Genentech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Participants | View |
Keywords: